1. Home
  2. ELTX vs MNTK Comparison

ELTX vs MNTK Comparison

Compare ELTX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$9.91

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo Montauk Renewables Inc.

MNTK

Montauk Renewables Inc.

HOLD

Current Price

$1.35

Market Cap

202.0M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
MNTK
Founded
2011
1980
Country
United States
United States
Employees
33
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
202.0M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
ELTX
MNTK
Price
$9.91
$1.35
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$18.00
$1.80
AVG Volume (30 Days)
112.2K
267.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
$176,382,000.00
Revenue This Year
N/A
$18.55
Revenue Next Year
N/A
$12.68
P/E Ratio
N/A
$146.00
Revenue Growth
N/A
0.37
52 Week Low
$5.80
$1.07
52 Week High
$14.93
$2.78

Technical Indicators

Market Signals
Indicator
ELTX
MNTK
Relative Strength Index (RSI) 38.27 47.64
Support Level $8.76 $1.08
Resistance Level $10.16 $1.58
Average True Range (ATR) 0.75 0.11
MACD -0.19 0.00
Stochastic Oscillator 2.14 11.11

Price Performance

Historical Comparison
ELTX
MNTK

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: